InvestorsHub Logo
Followers 44
Posts 10454
Boards Moderated 0
Alias Born 01/13/2016

Re: None

Thursday, 05/04/2023 8:03:58 AM

Thursday, May 04, 2023 8:03:58 AM

Post# of 4169
I don’t understand the value of
VIRI Pharma line as I delve into CNS area .
AVXL , anvs ..Bivi ..Rvph..

But .. the market place valued Viri at $160,000,000 BEfORE Phase 3 ..
success of phase 2 presumably would have pushed the valuation well past $200,000,000 or why would you value Viri at $160,000,000 BEFORE ?

So to my logic the Value of VIRI should be well past $10 per share since the FDA agrees that VIRI had a successful Phase 2!

Also seems to me ..and I am
Not a medical background kind of guy..
BUT if you do a Phase 3 focused as a First Response for Treatment..

the other drugs really don’t work( why would they let you be first) and if succesful YOU will own the market…

So seems to me.. not only was Phase 2 succesful but a homerun..

And they have another drug with data expected in June( next month) which is in an open label study..
Open Label.. Open Information..

Should be an exciting 30 days..

I don’t think $1,40 was right level for market makers to create their short level with 111,000,000 share volume..
they went by percentage gain ..but I think
they misread the room on Valuation..

We shall see
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VIRI News